A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study). Journal of affective disorders 2025 https://researcherprofiles.org/profile/679826119 40378969 Rothman B, Slomkowski M, Speier A, Rush AJ, Trivedi MH, Lakhan SE, Lawson E, Fahmy M, Carpenter D, Chen D, Docherty JP, Forbes A
